ProShares UltraShort NASDAQ Biotechnology
10 hedge funds and large institutions have $3.07M invested in ProShares UltraShort NASDAQ Biotechnology in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.
Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BG
1
Bellevue Group
Kuesnacht,
Switzerland
|
$426K |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$359K |
| 3 |
3
Morgan Stanley
New York
|
$16K |
| 4 |
4
Simplex Trading
Chicago,
Illinois
|
$5K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WP
1
WealthSource Partners
San Luis Obispo,
California
| $1.22M | 71,500 | -14,500 | -17% |
|
2
Citadel Advisors
Miami,
Florida
| $807K | 47,356 | -2,635 | -5% |
|
|
BG
3
Bellevue Group
Kuesnacht,
Switzerland
| $426K | 25,000 | +25,000 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $359K | 21,051 | +21,051 | New |
|
|
HF
5
HRT Financial
New York
| $210K | 12,369 | -1,309 | -10% |
|
|
6
Morgan Stanley
New York
| $16K | 958 | +576 | +151% |
|
7
UBS Group
Zurich,
Switzerland
| $12K | 723 | -1,531 | -68% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $6K | 374 | -38,084 | -99% |
|
9
Citigroup
New York
| $6K | 340 | – | – |
|
|
10
Simplex Trading
Chicago,
Illinois
| $5K | 296 | +296 | New |
|
|
VF
11
Virtu Financial
New York
| – | – | -19,069 | Closed |
|
|
CFGS
12
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|